Anpario Plc Ord 23P is listed on the London Stock Exchange trading with ticker code ANP.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £0.00, with approximately 23m shares in issue.
Anpario Plc, officially known as Anpario Plc Ord 23P was formed in April of 1997, making the company twenty two years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 26.57 million GBX with gross profits of 9.79 million, or 0.4227 per issued share, and a pre-tax profit margin of 12.49%. Anpario Plc currently has 5 directors, and has had 16 previous directors over the last 22 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 4.24 million paid in salaries to the 101 staff (average wage of 42 thousand), with the directors receiving an average 171 thousand each. In the accounts filed in 2014, the company paid 677000 in dividends, or 0.0292 per share. These accounts also showed Anpario Plc to have a net worth of 12.92 million, with 6.63 million held in cash.
Anpario Plc is in the Medicine and Biotech Research sector.
|Trakm8 Holdings Plc (TRAK.L)|
|Concha Plc (CHA.L)|
|Arbuthnot Banking Group Plc (ARBB.L)|
|Silence Therapeutics Plc (SLN.L)|
|Seeing Machines Limited (SEE.L)|
|Shares in Issue||23m|
|52 Week High||0.00|
|52 Week Low||0.00|